Prostate Cancer Trials
Statuses
Locations
TYPE
Prostate
STATUS
In Follow-up
LOCATION
NSW | VIC | QLD | SA | WA
PROTOCOL #
ANZUP 2101
ANZadapt
Phase II randomised controlled trial of patient-specific adaptive versus continuous Abiraterone or eNZalutamide in metastatic castration-resistant prostate cancer
Study testing whether adaptive (pause–restart) hormone treatment compared to continuous treatment improves outcomes for people with advanced prostate …
TYPE
Prostate
STATUS
Recruiting
LOCATION
NSW | VIC | WA
PROTOCOL #
ANZUP2205
DARO-LIPID
Randomised Phase 2 study of sphingosine kinase inhibitor (opaganib) in addition to darolutamide in people with poor prognostic metastatic castration …
Study testing whether adding a new treatment (opaganib) to standard therapy improves outcomes for a selected group of people with advanced, treatment …
TYPE
Prostate
STATUS
In Follow-up
LOCATION
NSW | VIC | QLD | SA | TAS | WA | NZ | Ireland | Canada | USA
PROTOCOL #
ANZUP 1801
TYPE
Prostate
STATUS
In Follow-up
LOCATION
NSW | VIC | QLD | SA | WA
PROTOCOL #
ANZUP 1901
ENZA-p
A randomised phase II trial using PSMA as a therapeutic agent and prognostic indicator in people with metastatic castration-resistant prostate cancer treated with enzalutamide.
Study testing whether adding a targeted radiation treatment (LuPSMA) to enzalutamide improves outcomes, and whether PSMA can help monitor disease prog…
TYPE
Prostate
STATUS
In Follow-up
LOCATION
NSW | VIC | QLD | NT | SA | TAS | WA | NZ | UK | Ireland | Canada | USA
PROTOCOL #
ANZUP 1304
TYPE
Prostate
STATUS
In Follow-up
LOCATION
NSW | VIC | QLD | SA | TAS | WA | NZ | UK | Ireland | Belgium | USA | Spain | Austria | Slovenia
PROTOCOL #
ANZUP 1303
ENZARAD
Enzalutamide in androgen deprivation therapy with radiation therapy for high risk, clinically localised, prostate cancer: a randomised phase III trial
Study testing whether adding enzalutamide to standard hormone therapy and radiation improves survival and quality of life for people with high-risk pr…
TYPE
Prostate
STATUS
In Follow-up
LOCATION
NSW | VIC | SA | WA
PROTOCOL #
ANZUP 2001
EVOLUTION
Phase II Study of Radionuclide 177Lu-PSMA Therapy versus 177Lu-PSMA in Combination with Ipilimumab and Nivolumab for people with Metastatic Castration Resistant Prostate Cancer
Study testing whether adding immunotherapy (ipilimumab and nivolumab) to a targeted radiation treatment (LuPSMA) improves outcomes for people with adv…
TYPE
Prostate
STATUS
Recruiting
LOCATION
NSW | VIC | QLD
PROTOCOL #
ANZUP2102
GenI-AIRSPACE
Evaluating the effect of genomically informed treatment decision-making on long-term oncological outcomes for individuals diagnosed with intermediate …
Study testing whether genetic test results can help guide decisions between active surveillance and treatment for people with intermediate-risk prosta…
TYPE
Prostate
STATUS
In Follow-up
LOCATION
NSW | VIC | QLD | SA | WA
PROTOCOL #
HREC/16/PMCC/130
proPSMA
A prospective randomised multi-centre study of the impact of Ga-68 PSMA-PET/CT imaging for staging high risk prostate cancer prior to curative-intent surgery or radiotherapy
Study testing whether a newer type of scan (PSMA PET/CT) can better detect cancer spread that may not be seen on standard scans and improve treatment …